IDC predicts that by 2027, the Asia/Pacific Healthcare industry will save up to $110 billion by significantly optimising clinical, operational, and administrative workflows through intelligent automation.
“New and emerging technologies are transforming digital healthcare in ways that were not possible just a few years ago,” says Louise Francis, head of public sector research, IDC Asia/Pacific, “but these opportunities must be counter-balanced against growing risks associated with many of those technologies to ensure patient safety and trust are not eroded.”
Tech predictions
In the report, IDC FutureScape: Worldwide Healthcare Industry 2025 Predictions – Asia Pacific (excluding Japan) Implications, IDC also reveals that around 40% of regional healthcare organisations intend to increase their IT budget for GenAI investments.
IDC predictions also show that by 2026, rapid use case deployment, more curated clinical data, and increased organisational buy-in will drive healthcare GenAI investments to double in the Asia Pacific, excluding Japan (APeJ).
However, numerous barriers such as data trustworthiness, disconnected workflows, and end-user resistance will cause most ((75%) Healthcare GenAI initiatives to fail to achieve expected benefits in APeJ by 2028.
By 2029, at least 40% of complex, high-volume surgeries at top APeJ hospitals will use AI-driven, real-time guidance, haptic feedback, and advanced analytics. IDC predicts such advancements will reduce surgical complications by 60%.
